Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Strategies for the Management of Patients With Major Depressive Disorder (MDD) and Suboptimal Response to Antidepressant Drugs in Primary Care: the Badalona Database Study

NCT01446692 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01446692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01446692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Strategies for the Management of Patients With Major Depressive Disorder (MDD) and Suboptimal Response to Antidepressant Drugs in Primary Care: the Badalona Database Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 30, 2011
Completion date
January 31, 2012
Enrollment
2,260 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder